PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes (PRECIDENTD)
PRECIDENTD: PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Sponsor: Brigham and Women's Hospital
This PHASE4 trial investigates ASCVD and Type2Diabetes and is currently actively recruiting participants. Brigham and Women's Hospital leads this study, which shows 8 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Dec 2025 — Present [monthly]
Recruiting PHASE4
-
Sep 2024 — Dec 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Jun 2024 — Jul 2024 [monthly]
Recruiting PHASE4
-
Aug 2023 — Jun 2024 [monthly]
Recruiting PHASE4
▶ Show 3 earlier versions
-
Jan 2023 — Aug 2023 [monthly]
Recruiting PHASE4
-
Sep 2022 — Jan 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jun 2022 — Sep 2022 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
- Patient-Centered Outcomes Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .